Theracosbio Is A Pharmaceutical Company Located In Marlboroughmassachusettsthe Company Focuses On Developing And Commercializing Innovative Therapeutics For Diseases That Significantly Impact Societytheir Mission Is To Provide Affordable Access To New Medications For Patients With Common Diseases Theracosbio S Primary Service Includes The Discoverydevelopmentand Commercialization Of Medicinesthey Aim To Tackle High Drug Costs By Offering New Treatments At Lower Pricesone Of Their Key Products Is Brenzavvybexagliflozin An Sglt2 Inhibitor Approved By The Fda In 2023 For Diabetes Managementthis Medication Is Part Of Their Strategy To Enhance Accessibility And Affordability In Diabetes Care The Company Has Partnered With Mark Cuban S Cost Plus Drug Company To Distribute Brenzavvy At A Transparent Priceallowing Patients To Access It Directly Through An Online Pharmacyadditionallythey Have A Royalty Financing Agreement With Healthcare Royaltyhcrxto Support The Distribution Of Brenzavvy And Maintain Its Affordabilitybrian Connelly Serves As The President And Ceo Of Theracosbio As Of 2023
No conferences found for this company.
| Company Name | Theracos Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
